Patents by Inventor Kevin M. Esvelt

Kevin M. Esvelt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230257781
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including use of multiple orthogonal Cas9 proteins to simultaneously and independently regulate corresponding genes or simultaneously and independently edit corresponding genes.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 17, 2023
    Inventors: George M. Church, Kevin M. Esvelt, Prashant G. Mali
  • Patent number: 11649469
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including use of multiple orthogonal Cas9 proteins to simultaneously and independently regulate corresponding genes or simultaneously and independently edit corresponding genes.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: May 16, 2023
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Kevin M. Esvelt, Prashant G. Mali
  • Publication number: 20230131972
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
    Type: Application
    Filed: October 25, 2022
    Publication date: April 27, 2023
    Inventors: George M. Church, Prashant G. Mali, Kevin M. Esvelt
  • Publication number: 20230039625
    Abstract: The invention relates, in part, to devices, systems and methods to increase the likelihood of survival and reproductive success of preselected organisms.
    Type: Application
    Filed: January 13, 2021
    Publication date: February 9, 2023
    Applicant: Massachusetts Institute of Technology
    Inventors: Kevin M. ESVELT, Sarah Anna VITAK
  • Publication number: 20200299732
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
    Type: Application
    Filed: April 17, 2020
    Publication date: September 24, 2020
    Inventors: George M. Church, Prashant G. Mali, Kevin M. Esvelt
  • Patent number: 10767194
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: September 8, 2020
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Prashant G. Mali, Kevin M. Esvelt
  • Patent number: 10752906
    Abstract: Stably immunized cells and methods of making stably immunized cells are provided. Methods of altering the microbiota of an ecological environment are provided. Methods of modifying target chromosomes are provided. Methods of delivering genetic material to target cells are provided.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: August 25, 2020
    Assignee: President and Fellows of Harvard College
    Inventors: Kevin M. Esvelt, Stephanie Yaung
  • Patent number: 10640789
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: May 5, 2020
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Prashant G. Mali, Kevin M. Esvelt
  • Publication number: 20200024618
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
    Type: Application
    Filed: June 14, 2019
    Publication date: January 23, 2020
    Applicant: President and Fellows of Harvard College
    Inventors: George M. Church, Prashant G. Mali, Kevin M. Esvelt
  • Patent number: 10526618
    Abstract: RNA guided Cas9 gene drives and method for their use are disclosed.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: January 7, 2020
    Assignee: President and Fellows of Harvard College
    Inventors: Kevin M. Esvelt, Andrea L. Smidler
  • Publication number: 20190367948
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including use of multiple orthogonal Cas9 proteins to simultaneously and independently regulate corresponding genes or simultaneously and independently edit corresponding genes.
    Type: Application
    Filed: May 14, 2019
    Publication date: December 5, 2019
    Inventors: George M. Church, Kevin M. Esvelt, Prashant G. Mali
  • Patent number: 10329587
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including use of multiple orthogonal Cas9 proteins to simultaneously and independently regulate corresponding genes or simultaneously and independently edit corresponding genes.
    Type: Grant
    Filed: July 8, 2014
    Date of Patent: June 25, 2019
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Kevin M. Esvelt, Prashant G. Mali
  • Publication number: 20190175762
    Abstract: Dependent gene drive systems and their use in genome editing are disclosed. Methods of making a genome editing system using dependent gene drives are also disclosed.
    Type: Application
    Filed: September 28, 2016
    Publication date: June 13, 2019
    Applicant: President and Fellows of Harvard College
    Inventors: Kevin M. Esvelt, Jianghong Min
  • Publication number: 20160348120
    Abstract: Stably immunized cells and methods of making stably immunized cells are provided. Methods of altering the microbiota of an ecological environment are provided. Methods of modifying target chromosomes are provided. Methods of delivering genetic material to target cells are provided.
    Type: Application
    Filed: November 5, 2014
    Publication date: December 1, 2016
    Applicants: President and Fellows of Harvard College, President and Fellows of Harvard College
    Inventors: Kevin M. Esvelt, Stephanie Yaung
  • Publication number: 20160333376
    Abstract: RNA guided Cas9 gene drives and method for their use are disclosed.
    Type: Application
    Filed: June 3, 2016
    Publication date: November 17, 2016
    Inventors: Kevin M. Esvelt, Andrea L. Smidler
  • Publication number: 20160237456
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
    Type: Application
    Filed: February 22, 2016
    Publication date: August 18, 2016
    Inventors: George M. Church, Prashant G. Mali, Kevin M. Esvelt
  • Publication number: 20160222416
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including use of multiple orthogonal Cas9 proteins to simultaneously and independently regulate corresponding genes or simultaneously and independently edit corresponding genes.
    Type: Application
    Filed: July 8, 2014
    Publication date: August 4, 2016
    Inventors: George M. Church, Kevin M. Esvelt, Prashant G. Mali
  • Patent number: 9267135
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: February 23, 2016
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Prashant G. Mali, Kevin M. Esvelt
  • Patent number: 9023594
    Abstract: The present invention discloses generalizable methods of evolving nucleic acids and proteins utilizing continuous directed evolution. The invention discloses methods of passing a nucleic acid from cell to cell in a desired function-dependent manner. The linkage of the desired function and passage of the nucleic acid from cell to cell allows for continuous selection and mutation of the nucleic acid.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: May 5, 2015
    Assignee: President and Fellows of Harvard College
    Inventors: David R. Liu, Kevin M. Esvelt
  • Publication number: 20140356959
    Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.
    Type: Application
    Filed: June 30, 2014
    Publication date: December 4, 2014
    Inventors: George M. CHURCH, Prashant G. MALI, Kevin M. ESVELT